|
Re: Nothing to do but sit back and wait......
|
6
|
Resverlogix Corp.
|
Oct 01, 2015 03:56PM
|
|
Re: Zenith AGM
|
6
|
Zenith Epigenetics
|
Nov 24, 2023 08:38AM
|
|
Re: Exempt Distribution - 2022-04-14
|
6
|
Resverlogix Corp.
|
Apr 19, 2022 12:08PM
|
|
Re: Interesting.
|
6
|
Resverlogix Corp.
|
Nov 23, 2021 10:33AM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
6
|
Resverlogix Corp.
|
Nov 17, 2015 01:15PM
|
|
CEPT and BP
|
6
|
Resverlogix Corp.
|
Sep 04, 2017 11:19AM
|
|
Re: Resverlogix Special Meeting Jun 30 9am MDT
|
6
|
Resverlogix Corp.
|
Jul 01, 2015 11:28AM
|
|
Re: We might already be at 125 events....
|
6
|
Resverlogix Corp.
|
Oct 25, 2017 04:38PM
|
|
Re: Don't See Us Listed but thought it might interest some
|
6
|
Resverlogix Corp.
|
Mar 10, 2021 11:57AM
|
|
Re: Australia Associated Press
|
6
|
Resverlogix Corp.
|
Mar 03, 2021 06:17PM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
6
|
Zenith Epigenetics
|
Nov 20, 2018 03:23PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
6
|
Zenith Epigenetics
|
Sep 26, 2024 11:51AM
|
|
Re: Richmond Club presentation
|
6
|
Resverlogix Corp.
|
Mar 30, 2016 04:47PM
|
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 09, 2022 06:29PM
|
|
Re: A comment about market penetration
|
6
|
Resverlogix Corp.
|
Mar 20, 2017 04:25PM
|
|
Re: My conversation with Don....
|
6
|
Resverlogix Corp.
|
Dec 02, 2017 12:05PM
|
|
Thoughts on ZCC
|
6
|
Zenith Epigenetics
|
Sep 02, 2021 12:22PM
|
|
Voting reminder
|
6
|
Resverlogix Corp.
|
Jun 08, 2023 12:39PM
|
|
Re: Something Doesn't Add Up
|
6
|
Resverlogix Corp.
|
Aug 17, 2015 11:05AM
|
|
Re: Round one
|
6
|
Resverlogix Corp.
|
Jan 27, 2022 01:17PM
|
